We narrowed to 7,806 results for: ttl

Showing: 1421 - 1440 of 7806 results

Results per page:

Sort results by:

pDONR221_SLC22A8

Plasmid

#131989

Purpose

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

Depositor

RESOLUTE Consortium, Giulio Superti-Furga

Publication

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Insert

SLC22A8 (SLC22A8 Human)

Expression

Mammalian

Available since

Oct. 22, 2019

Availability

Industry, Academic Institutions, and Nonprofits

Cited by

1 Article

Enlarge
pDONR221_SLC25A46

Plasmid

#131971

Purpose

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

Depositor

RESOLUTE Consortium, Giulio Superti-Furga

Publication

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Insert

SLC25A46 (SLC25A46 Human)

Expression

Mammalian

Available since

Oct. 21, 2019

Availability

Industry, Academic Institutions, and Nonprofits

Cited by

1 Article

Enlarge
pDONR223_SHC1_WT_V5

Plasmid

#82931

Purpose

Gateway Donor vector containing SHC1, used as an over expression control for gene expression analysis. Part of the Target Accelerator Plasmid Collection.

Depositor

Jesse Boehm, Matthew Meyerson, David Root

Publication

Berger et al Cancer Cell. 2016 Aug 8;30(2):214-28. do

Insert

SHC1 (SHC1 Human)

Use

Gateway Cloning

Promoter

None

Available since

April 24, 2017

Availability

Academic Institutions and Nonprofits only

Enlarge
pME-NLStdMCP- tagRFP

Plasmid

#86244

Purpose

Middle entry vector for inserting promotors for tissue specific expression of NLS-tdMCP-tagRFP

Depositor

Florence Marlow

Publication

Campbell et al Development. 2015 Apr 1;142(7):1368-74.

Type

Empty backbone

Use

Unspecified

Tags

NLS-tdMCP-tagRFP

Available since

Jan. 25, 2017

Availability

Academic Institutions and Nonprofits only

Enlarge
pDONR221_SLC38A9

Plasmid

#132070

Purpose

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

Depositor

RESOLUTE Consortium, Giulio Superti-Furga

Publication

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Insert

SLC38A9 (SLC38A9 Human)

Expression

Mammalian

Available since

Nov. 8, 2019

Availability

Industry, Academic Institutions, and Nonprofits

Cited by

2 Articles

Enlarge
pDONR223_GEN1_WT

Plasmid

#81844

Purpose

Gateway Donor vector containing GEN1 , part of the Target Accelerator Plasmid Collection.

Depositor

Jesse Boehm, William Hahn, David Root

Publication

Kim et al Cancer Discov. 2016 Jul;6(7):714-26. doi

Insert

GEN1 (GEN1 Human)

Use

Gateway Cloning

Mutation

S92T

Promoter

None

Available since

April 24, 2017

Availability

Academic Institutions and Nonprofits only

Enlarge
pME-TagBFP2-NS

Plasmid

#80502

Purpose

Multisite gateway entry clone for adding N-terminal fusions of TagBFP2

Depositor

Rob Parton

Publication

Hall et al Cell Logist. 2017 Mar 1;7(1):e1301151. d

Insert

TagBFP2 (no STOP)

Use

Multisite gateway middle entry clone

Available since

April 12, 2017

Availability

Academic Institutions and Nonprofits only

Enlarge
pEnt L1L3 tTA-2

Plasmid

#24414

Depositor

Edward Hsiao

Publication

Hsiao et al Stem Cell Res Ther. 2011 Mar 4. 2(2):11.

Type

Empty backbone

Use

Gateway Cloning

Available since

June 4, 2010

Availability

Academic Institutions and Nonprofits only

Enlarge
pENTR223-BALF4

Plasmid

#195835

Purpose

Gateway Entry Clone of Epstein-Barr virus BALF4

Depositor

Eric Johannsen

Publication

Calderwood et al Proc Natl Acad Sci U S A. 2007 May 1;104

Insert

BALF4 (BALF4 Epstein-Barr virus)

Use

Gateway Cloning

Available since

May 19, 2023

Availability

Academic Institutions and Nonprofits only

Enlarge
pDONR221-SLC5A5_STOP

Plasmid

#161348

Purpose

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors. Contains a STOP codon at the end of the codon-optimized ORF sequence.

Depositor

RESOLUTE Consortium, Giulio Superti-Furga

Publication

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Insert

SLC5A5 (SLC5A5 Human)

Expression

Mammalian

Available since

Sept. 15, 2021

Availability

Industry, Academic Institutions, and Nonprofits

Cited by

1 Article

Enlarge
pDONR221_SLC26A5

Plasmid

#132044

Purpose

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

Depositor

RESOLUTE Consortium, Giulio Superti-Furga

Publication

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Insert

SLC26A5 (SLC26A5 Human)

Expression

Mammalian

Available since

Nov. 4, 2019

Availability

Industry, Academic Institutions, and Nonprofits

Cited by

1 Article

Enlarge
pDONR221_SLC16A11

Plasmid

#131939

Purpose

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

Depositor

RESOLUTE Consortium, Giulio Superti-Furga

Publication

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Insert

SLC16A11 (SLC16A11 Human)

Expression

Mammalian

Available since

Oct. 17, 2019

Availability

Industry, Academic Institutions, and Nonprofits

Cited by

1 Article

Enlarge
pENTR U6-hTERTsh

Plasmid

#111385

Purpose

Knock down of hTERT transcript

Depositor

Klaus Holzmann

Publication

Kreilmeier et al Genes (Basel). 2016 Aug 16;7(8). pii: ge

Insert

shRNA C3 against hTERT

Use

Gateway entry cloning

Promoter

U6

Available since

Aug. 9, 2018

Availability

Academic Institutions and Nonprofits only

Enlarge
pSC10

Plasmid

#104784

Purpose

pAH595-gRNA 2xplex entry cassette

Depositor

Robert Stupar

Publication

Curtin et al Plant Biotechnol J. 2017 Oct 31. doi: 10

Type

Empty backbone

Use

CRISPR

Expression

Plant

Available since

May 15, 2018

Availability

Academic Institutions and Nonprofits only

Cited by

1 Article

Enlarge
pDONR223_MAGEC2_WT

Plasmid

#81862

Purpose

Gateway Donor vector containing MAGEC2 , part of the Target Accelerator Plasmid Collection.

Depositor

Jesse Boehm, William Hahn, David Root

Publication

Kim et al Cancer Discov. 2016 Jul;6(7):714-26. doi

Insert

MAGEC2 (MAGEC2 Human)

Use

Gateway Cloning

Mutation

WT

Promoter

None

Available since

April 24, 2017

Availability

Academic Institutions and Nonprofits only

Cited by

1 Article

Enlarge
pDONR223_DIABLO_WT

Plasmid

#82257

Purpose

Gateway Donor vector containing DIABLO , part of the Target Accelerator Plasmid Collection.

Depositor

Jesse Boehm, William Hahn, David Root

Publication

Kim et al Cancer Discov. 2016 Jul;6(7):714-26. doi

Insert

DIABLO (DIABLO Human)

Use

Gateway Cloning

Mutation

WT

Promoter

None

Available since

April 24, 2017

Availability

Academic Institutions and Nonprofits only

Enlarge
pDONR223_CRY1_WT

Plasmid

#82264

Purpose

Gateway Donor vector containing CRY1 , part of the Target Accelerator Plasmid Collection.

Depositor

Jesse Boehm, William Hahn, David Root

Publication

Kim et al Cancer Discov. 2016 Jul;6(7):714-26. doi

Insert

CRY1 (CRY1 Human)

Use

Gateway Cloning

Mutation

WT

Promoter

None

Available since

April 24, 2017

Availability

Academic Institutions and Nonprofits only

Cited by

1 Article

Enlarge
pME-TurboID-NS

Plasmid

#166566

Purpose

Multisite Gateway middle entry clone encoding TurboID. Parton lab clone JRP

Depositor

Rob Parton

Publication

Xiong et al Elife. 2021 Feb 16;10. pii: 64631. doi:

Has service

50 µg Transfection-Ready DNA and 100 µg Transfection-Ready DNA

Insert

TurboID

Use

Gateway Cloning

Available since

Sept. 13, 2021

Availability

Academic Institutions and Nonprofits only

Enlarge
pDONR221_SLC6A20

Plasmid

#132243

Purpose

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

Depositor

RESOLUTE Consortium, Giulio Superti-Furga

Publication

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Insert

SLC6A20 (SLC6A20 Human)

Expression

Mammalian

Available since

Nov. 21, 2019

Availability

Industry, Academic Institutions, and Nonprofits

Cited by

1 Article

Enlarge
pDONR221_SLC9A6

Plasmid

#132175

Purpose

Gateway entry clone with codon-optimized ORF sequence for subcloning into custom expression vectors

Depositor

RESOLUTE Consortium, Giulio Superti-Furga

Publication

Superti-Furga et al Nat Rev Drug Discov. 2020 Jul;19(7):429-

Insert

SLC9A6 (SLC9A6 Human)

Expression

Mammalian

Available since

Oct. 25, 2019

Availability

Industry, Academic Institutions, and Nonprofits

Cited by

3 Articles

Enlarge